Literature DB >> 17082595

Fc receptor homolog 3 is a novel immunoregulatory marker of marginal zone and B1 B cells.

Woong-Jai Won1, Jeremy B Foote, Mary R Odom, Jicun Pan, John F Kearney, Randall S Davis.   

Abstract

Two members of the recently identified FcR homolog (FcRH) family in mice demonstrate preferential B cell expression. One of these, FcRH3, encodes a type I transmembrane protein with five extracellular Ig domains and a cytoplasmic tail with a consensus ITIM and a noncanonical ITAM. Analysis of full-length cDNAs from five different mouse strains defines two FcRH3 alleles. A panel of FcRH3-specific mAbs was generated to define its expression pattern and functional potential on B lineage cells. Although poorly detected on the majority of bone marrow or peripheral blood cells, FcRH3 was readily identified on splenic marginal zone (MZ) and MZ precursor B cells, but not on the bulk of newly formed B cells, follicular B cells, germinal center B cells, and plasma cells. In the peritoneal cavity, FcRH3 was found on B1 cells, and not on the majority of B2 cells. Consistent with its possession of an ITIM and ITAM-like sequence, FcRH3 was tyrosine phosphorylated following pervanadate treatment, and its coligation with the BCR inhibited calcium mobilization. These results suggest FcRH3 is a novel immunoregulatory marker of MZ and B1 B lineage cells.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17082595     DOI: 10.4049/jimmunol.177.10.6815

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  19 in total

1.  DNA microarray gene expression profile of marginal zone versus follicular B cells and idiotype positive marginal zone B cells before and after immunization with Streptococcus pneumoniae.

Authors:  Nicholas W Kin; Dianna M Crawford; Jiabin Liu; Timothy W Behrens; John F Kearney
Journal:  J Immunol       Date:  2008-05-15       Impact factor: 5.422

2.  Migration of immature and mature B cells in the aged microenvironment.

Authors:  Heather A Minges Wols; Kara M Johnson; Jill A Ippolito; Shirin Z Birjandi; Yan Su; Phong T Le; Pamela L Witte
Journal:  Immunology       Date:  2009-10-21       Impact factor: 7.397

3.  FCRL5 exerts binary and compartment-specific influence on innate-like B-cell receptor signaling.

Authors:  Zilu Zhu; Ran Li; Hao Li; Tong Zhou; Randall S Davis
Journal:  Proc Natl Acad Sci U S A       Date:  2013-03-18       Impact factor: 11.205

Review 4.  Emerging roles for the FCRL family members in lymphocyte biology and disease.

Authors:  F J Li; W J Won; E J Becker; J L Easlick; E M Tabengwa; R Li; M Shakhmatov; K Honjo; P D Burrows; R S Davis
Journal:  Curr Top Microbiol Immunol       Date:  2014       Impact factor: 4.291

5.  EBI2 overexpression in mice leads to B1 B-cell expansion and chronic lymphocytic leukemia-like B-cell malignancies.

Authors:  Kristine Niss Arfelt; Line Barington; Tau Benned-Jensen; Valentina Kubale; Alexander L Kovalchuk; Viktorija Daugvilaite; Jan Pravsgaard Christensen; Allan Randrup Thomsen; Kristoffer L Egerod; Maria R Bassi; Katja Spiess; Thue W Schwartz; Hongsheng Wang; Herbert C Morse; Peter J Holst; Mette M Rosenkilde
Journal:  Blood       Date:  2016-12-21       Impact factor: 22.113

6.  Ligation of human Fc receptor like-2 by monoclonal antibodies down-regulates B-cell receptor-mediated signalling.

Authors:  Mahdi Shabani; Ali Ahmad Bayat; Mahmood Jeddi-Tehrani; Hodjatallah Rabbani; Mohammad Hojjat-Farsangi; Cristina Ulivieri; Zahra Amirghofran; Cosima Tatiana Baldari; Fazel Shokri
Journal:  Immunology       Date:  2014-11       Impact factor: 7.397

7.  FCRL3 promotes TLR9-induced B-cell activation and suppresses plasma cell differentiation.

Authors:  Fu Jun Li; Daniel M Schreeder; Ran Li; Jiongru Wu; Randall S Davis
Journal:  Eur J Immunol       Date:  2013-08-12       Impact factor: 5.532

8.  Neonatal Exposure to Commensal-Bacteria-Derived Antigens Directs Polysaccharide-Specific B-1 B Cell Repertoire Development.

Authors:  J Stewart New; Brian L P Dizon; Christopher F Fucile; Alexander F Rosenberg; John F Kearney; R Glenn King
Journal:  Immunity       Date:  2020-06-30       Impact factor: 31.745

9.  FCRL2 expression predicts IGHV mutation status and clinical progression in chronic lymphocytic leukemia.

Authors:  Fu Jun Li; Shouluan Ding; Jicun Pan; Mikhail A Shakhmatov; Elena Kashentseva; Jiongru Wu; Yufeng Li; Seng-jaw Soong; Nicholas Chiorazzi; Randall S Davis
Journal:  Blood       Date:  2008-02-26       Impact factor: 22.113

10.  Fc receptor-like 5 inhibits B cell activation via SHP-1 tyrosine phosphatase recruitment.

Authors:  Christopher L Haga; Götz R A Ehrhardt; Rebecca J Boohaker; Randall S Davis; Max D Cooper
Journal:  Proc Natl Acad Sci U S A       Date:  2007-05-23       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.